2 studies found for:    20538001 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients With Benign Colorectal Polyps
Condition: Colorectal Cancer
Intervention: Drug: eflornithine plus sulindac
2 Completed Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
Condition: Precancerous Condition
Interventions: Other: placebo;   Drug: eflornithine;   Drug: sulindac;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years